| ADT | Androgen deprivation therapy |
| ALDH | Aldehyde dehydrogenase |
| BMP | Bone morphogenetic protein |
| CAF | Cancer-associated fibroblasts |
| CSC | Cancer stem cell |
| CUDR | Cancer up-regulated drug resistant |
| DMR | Differentially methylated region |
| EGFR | Epidermal growth factor receptor |
| EMT | Epidermal-to-mesenchymal transition |
| ERβ | Estrogen receptor β |
| GST-π | Glutathione S-transferase-π |
| HDAC | Histone deacetylase |
| HIF-1α | Hypoxia-inducible factor 1 alpha |
| HMGA2 | High mobility group AT-hook 2 |
| HSC | Hematopoietic stem cells |
| IGF1R | Insulin-like growth factor 1 receptor |
| IGF2 | Insulin-like growth factor 2 |
| IPS | Induced-pluripotent cells |
| KRAS | V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
| LncRNA | Long non-coding RNA |
| MDR1 | Multidrug resistance 1 |
| miRNA | MicroRNA |
| PDK1 | Pyruvate dehydrogenase kinase 1 |
| PRC2 | Polycomb repressive complex 2 |
| PTEN | Phosphatase and tensin homolog |
| RB | Retinoblastoma protein |
| ROS | Reactive oxygen species |
| RUNX1 | Runt-related transcription factor 1 |
| SC | Stem cell |
| TNM | Tumor node metastasis |